--> --> -->

Global Ocular Drug Delivery Mode Market Analysis, 2020

By Disease Type (Diabetic Retinopathy, Diabetic Macular Edema, Dry Eye Syndrome, Glaucoma, Macular Degeneration, Cataract, Others), By Technology (Topical Iontophoresis, Ocular Insert [Erodible, Non-Erodible], Intraocular Implants [Biodegradable, Non-Biodegradable], In Situ Gel & Punctal Plugs, Others), By Formulation Type (Liposomes & Nanoparticles, Solution, Emulsion, Suspension, Ointment), By End-user (Hospitals, Ophthalmic Clinics, Ambulatory Surgical Centers, Homecare Settings), By Region (North America, South America, Europe, Asia-Pacific, Middle East & Africa), By Country (US, Canada, Brazil, Argentina, UK, Germany, France, Italy, Spain, China, Japan, South Korea, India, South East Asia, UAE, Saudi Arabia, Turkey, South Africa), By Company (Valeant Pharmaceuticals International, Inc., Taiwan Liposome Company, Ltd., Ocular Therapeutix, Inc., Graybug Vision Inc., Eyegate Pharma, Clearside Biomedical, Inc., Alimera Sciences, Envisia Therapeutics, Allergan, Plc.)

  • Healthcare
  • Sep 2020
  • 182
  • HC22040